FIELD: medicine.
SUBSTANCE: it has been shown that in the functional muscle discharge, PD150606 blocked the calpain proteolytic system leading to the protein breakdown, which leads to prevention of atrophic processes. The invention is characterised by preventing thereby for a long period of time, as PD150606 does not decrease the NO production by the muscles. The invention can find application in space medicine to remedy the negative effect of hypokinesia or discharge by gravity.
EFFECT: reducing protein destruction of atrophied skeletal muscles caused by hypokinesia or discharge by gravity.
6 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING AND REDUCING DESTRUCTION OF SKELETAL PROTEINS OF ATROPHIED SKELETAL MUSCLES CAUSED BY HYPOKINESIA AND/OR DISCHARGE BY GRAVITY | 2013 |
|
RU2517259C1 |
METHOD FOR PREVENTION OF SKELETAL MUSCLE ATROPHY AFTER FUNCTIONAL UNLOADING | 2012 |
|
RU2481105C1 |
USE OF VX 745 TO PREVENT SKELETAL MUSCLE ATROPHY WITH FUNCTIONAL DISCHARGE | 2019 |
|
RU2714923C1 |
METHOD OF PREVENTING ATROPHY OF SKELETAL MUSCLES DURING THEIR FUNCTIONAL UNLOADING | 2022 |
|
RU2797216C1 |
METHOD FOR PREVENTING AND REDUCING DESTRUCTION OF CYTOSKELETAL PROTEINS OF ATROPHIED SKELETAL MUSCLES CAUSED BY HYPOKINESIA AND/OR DISCHARGE BY GRAVITY | 2010 |
|
RU2444354C2 |
INHIBITOR OF EXERTIONAL CYTOSKELETAL PROTEOLYSIS OF SKELETAL MUSCLES | 2008 |
|
RU2389486C1 |
METHOD OF PREVENTING CYTOSCELETAL PROTEINS DESTRUCTION IN SCELETAL MUSCLES WITHIN ECCENTRIC LOAD | 2008 |
|
RU2391968C1 |
METHOD OF DETERMINING THE RISK OF MALIGNANT TRANSFORMATION OF EPITHELIAL CELLS OF THE LARYNX IN PATIENTS WITH PRECANCEROUS DISEASES OF THE LARYNX | 2022 |
|
RU2803858C1 |
METHOD TO PREVENT DEVELOPMENT OF SKELETAL MUSCLE FATIGUE | 2023 |
|
RU2814077C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING DISTANT METASTASES IN PATIENTS WITH OPERABLE FORMS OF BREAST CANCER WITH METASTASES IN REGIONAL LYMPH NODES | 2020 |
|
RU2733697C1 |
Authors
Dates
2014-05-27—Published
2013-03-06—Filed